Medicines used for Multiple Sclerosis – A Health Technology Assessment
dc.contributor.author | Couto, Elisabeth | |
dc.contributor.author | Hamidi Ashtiani, Vida | |
dc.contributor.author | Ringerike, Tove | |
dc.contributor.author | Odgaard-Jensen, Jan | |
dc.contributor.author | Harboe, Ingrid | |
dc.contributor.author | Klemp, Marianne | |
dc.date.accessioned | 2022-04-11T06:10:42Z | |
dc.date.available | 2022-04-11T06:10:42Z | |
dc.date.created | 2022-04-08T12:38:02Z | |
dc.date.issued | 2016 | |
dc.identifier.isbn | 978-82-8082-706-7 | |
dc.identifier.uri | https://hdl.handle.net/11250/2990834 | |
dc.language.iso | eng | |
dc.publisher | Norwegian Institute of Public Health | |
dc.relation.uri | https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2016/rapport_2016_ms-legemidlerv5.pdf | |
dc.title | Medicines used for Multiple Sclerosis – A Health Technology Assessment | |
dc.title.alternative | Medicines used for Multiple Sclerosis – A Health Technology Assessment | |
dc.title.alternative | Fullstendig metodevurdering av legemidler ved multippel sklerose | |
dc.type | Research report | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 234 | |
dc.identifier.cristin | 2016177 | |
cristin.ispublished | true | |
cristin.fulltext | original |